Sadra Medical Journal

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

News

Comparison of the Effectiveness of Gestalt Therapy, Behavioral Activation and Placebo on the Cognitive Emotion Regulation in Multiple Sclerosis Patients: A Randomized Clinical Trial

Document Type : Original Article

Authors

1 Ph.D. Student of Clinical Psychology, Department of Clinical Psychology, Roudehen Branch, Islamic Azad University, Roudehen, Iran

2 Associate ProfessorAssociate Professor of Clinical Psychology, Department of Clinical Psychology, Roudehen Branch, Islamic Azad University, Roudehen, Iran

3 Professor of Neurology, Department of Neurology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

4 Associate Professor of Psychology, Department of Clinical Psychology, Kharazmi University, Tehran, Iran

Abstract

Introduction: Psychological state of multiple sclerosis patients is very important due to its strong influence on incidence, progression, prognosis, and treatment of this disease. The present study compared the effectiveness of gestalt therapy, behavioral activation and placebo on cognitive emotion regulation in Multiple Sclerosis patients.
Methods: This study was a quasi-experimental pretest-posttest design with a control group and three months follow-up in which sixty patients with multiple sclerosis referred to the MS Clinic of Rasoul Hospital in Tehran were selected. Using four blocks, the authors randomly assigned participants to four groups of 15 people, including three intervention groups and a control group. Members of psychotherapy groups were treated once a week for eight 90-minute sessions. In the placebo group, capsules containing rice flour were used once a day for 8 weeks.  The people in the control group received no intervention during this period. The research instrument was Garnefski's (2006) Cognitive Emotion Regulation Questionnaire. SPSS (25) was used for data analysis.
Results: The results showed that gestalt therapy and behavioral activation in comparison with placebo and control groups increased the mean scores of adaptive cognitive emotion regulation strategies (p=0.001) and decreased the mean scores of non-adaptive strategies (p=0.001) in post-test and follow-up. Gestalt therapy, in comparison with behavioral activation, increased the mean scores of adaptive strategies (p=0.027) and also decreased the mean scores of non-adaptive strategies (p= 0.020) more significantly in post-test and follow-up.
Conclusion: Gestalt therapy is more effective than behavioral activation and placebo in improving cognitive emotion regulation in patients with multiple sclerosis.

Keywords

References
  1. Huang YC, Chien WC, Chung CH, Chang HA, Kao YC, Wan FJ, et al. Risk of Psychiatric Disorders in Multiple Sclerosis: A Nationwide Cohort Study in an Asian Population. Neuropsychiatr Dis Treat. 2021;17:587-604. https://doi.org/10.2147/NDT.S268360
  2. Wallin MT, Culpepper WJ, Nichols E, Bhutta ZA, Gebrehiwot TT, Hay SI, et al. Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. 2019 March; 18(3): 269-85. https://doi.org/10.1016/S1474-4422(18) 30443-5
  3. Dobson R, Giovannoni Multiple sclerosis–a review. Eur J Neurol. 2019 Oct; 26 (1): 27-40. https://doi.org/10.1111/ene.13819
  4. Amini P, Almasi-Hashiani A, Sahraian MA, Najafi M, Eskandarieh S. Multiple sclerosis projection in Tehran, Iran using Bayesian structural time series. BMC neurology. 2021 Dec;21(1) :1-6.https://doi.org/10.1186/s12883-021-02281-x
  5. Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, et Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS. Mult Scler J. 2020;26(14) :1816-21. https://doi.org/10.1177/1352458520970841
  6. Pfaff L, Lamy J, Noblet V, Gounot D, Chanson J-B, de Seze J, et al. Emotional disturbances in multiple sclerosis: A neuropsychological and fMRI study. Cortex. 2019 Aug;117:205-16. https://doi.org/10.1016/j.cortex.2019.02.017
  7. Pfaff L, Gounot D, Chanson JB, de Seze J, Blanc F. Emotional experience is increased and emotion recognition decreased in multiple sclerosis. Scientific Reports. 2021 Nov 8; 11(1):1-2. https://doi.org/10.1038/s41598-021-01139-z
  8. Garnefski N, Kraaij V. Cognitive emotion regulation questionnaire–development of a short 18-item version (CERQ-short). Personality and individual differences. 2006 Oct 1;41(6) :1045-53.https://doi.org/10.1016/j.paid.2006.04.010
  9. Kraaij V, Garnefski N. The behavioral emotion regulation questionnaire: development, psychometric properties and relationships with emotional problems and the cognitive emotion regulation questionnaire. Personality and Individual Differences. 2019 Jan 15;137:56-61. https://doi.org/10.1016/j.paid.2018.07.036
  10. Phillips LH, Henry JD, Nouzova E, Cooper C, Radlak B, Summers F. Difficulties with emotion regulation in multiple sclerosis: Links to executive function, mood, and quality of life. Journal of clinical and experimental neuropsychology. 2014 Sep 14;36(8) :831-42. https://doi.org/10.1080/13803395.2014.946891
  11. Raffagnino R. Gestalt therapy effectiveness: A systematic review of empirical evidence. Open Journal of Social Sciences. 2019 Jun 3;7(6) :66-83. https://doi.org/10.4236/jss.2019.76005
  12. Brownell P. Handbook for theory, research, and practice in Gestalt therapy: Cambridge Scholars Publishing; 2019.
  13. Spagnuolo Lobb M. Gestalt therapy during coronavirus: Sensing the experiential ground and “dancing” with reciprocity. The Humanistic Psychologist. 2020 Dec;48(4) :397. https://doi.org/10.1037/hum0000228
  14. Martell CR, Dimidjian S, Herman-Dunn R. Behavioral activation for depression: A clinician's guide. Guilford Publications; 2021 Nov 11.
  15. Enck P, Klosterhalfen S. The placebo and nocebo responses in clinical trials in inflammatory bowel diseases. Frontiers in Pharmacology. 2021 Mar 31; 12: 255. https://doi.org/10.3389/fphar.2021.641436
  16. Cohen L, Manion L, Morrison K. Research Methods in Behavioral Sciences. Routledge; 2018 PP:202-226.
  17. Joyce P, Sills C. Skills in Gestalt counselling & psychotherapy: Sage; 2018.
  18. Gollan J, Atlis M, Marlow-O’Connor MJUmCUoC. Behavioral activation: Group treatment for depression (pilot version). 2003.
  19. Besharat MA. Cognitive Emotion Regulation Questionnaire: Instruction and Scoring (Persian Version). Developmental Pschology: Iranian Psychologists. 2017;13(50) :3. [Article in persian].
  20. Mohsenabadi H, Fathi-Ashtiani A. Evaluation of psychometric properties of the Persian version of the short form of Cognitive Emotion Regulation Questionnaire (CERQ-18). Journal of the Iranian Institute for Health Sciences Research: Payesh. 2021; 20 (2) :167-178. [Article in persian]. https://doi.org/10.52547/payesh.20.2.167
  21. Torabian Sa-S, Mohammadi N, Rahimi C, Sivandzadeh Gr. The Effectiveness of Gestalt Therapy on Cognitive Emotion Regulation Strategies in Patients with Irritable Bowel Syndrome: A case study. Journal of Nursing Education (JNE).2021 March; 9(6): 73-84. [Article in persian].
  22. Fourure S. Emotional Regulation in Heart Gestalt-therapy. Gestalt. 2014; 44 (1): 143-54. https://doi.org/10.3917/gest.044.0143
  23. Zabihi h. Evaluation of the effectiveness of gestalt group therapy on cognitive emotion regulation in divorced women: shahid beheshti university; 2018.
  24. Janowski M, Biedrycka M. The effectiveness of gestalt therapy in the area of emotion regulation conducted in patients with neurotic/anxiety disorders. Psychoterapia. 2014; 171 (4): 63-75. https://doi.org/10.12740/PT/30926
  25. Orfanos P. A Critical Perspective of the Gestalt Therapeutic Approach. International Journal of Humanities and Social Sciences. 2021; 13(2): 108-18. https://doi.org/10.26803/ijhss.13.2.7
  26. Maan D. Gestalt therapy 100 Key Points and Techniques. 1st ed. Routledg. 2010;pp:1-276.
  27. Wheeler G. & Axelsson L. Gestalt Washington, DC 2002, American psychological association. 2015. https://doi.org/10.1037/14527-000
  28. Merizzi A, Biasi R, Zamudio JFÁ, Spagnuolo-Lobb M, Santini S. A single-case design investigation for measuring the efficacy of Gestalt therapy to treat depression in older adults with dementia in Italy and in Mexico: a research protocol. Preprints 2022. https://doi.org/10.20944/preprints202201.0267.v1
  29. Uphoff E, Ekers D, Robertson L, Dawson S, Sanger E, South E, Samaan Z, Richards D, Meader N, Churchill R. Behavioural activation therapy for depression in adults. Cochrane Database of Systematic Reviews. 2020(7). https://doi.org/10.1002/14651858.CD013305.pub2
  30. Malik K, Ibrahim M, Bernstein A, Venkatesh RK, Rai T, Chorpita B, Patel V. Behavioral Activation as an ‘active ingredient’ of interventions addressing depression and anxiety among young people: a systematic review and evidence synthesis. BMC psychology. 2021 Dec;9(1) :1-23. https://doi.org/10.1186/s40359-021-00655-x.
  31. Bedayat E, Askary M. The Effectiveness of Behavioral Activation Group Therapy on Emotional Regulation and Suicidal Ideation Strategies in Female Students with Major Depressive Disorder. Rooyesh-e-Ravanshenasi Journal (RRJ). 2020 Mar 10; 9(1): 47-56.
Sadra Medical Journal
Volume 10, Issue 1
January 2022
Pages 63-78
Files
Share
How to cite
Statistics